Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 1977 of 6351
-
CBD oil studied as a treatment for severe behavioral issues in kids with intellectual disability
Symptom relief CompletedThis is a multi-site, double-blind, parallel group, randomized, placebo-controlled study of 140 participants comparing oral purified cannabidiol isolate (CBD) with placebo in reducing Severe Behavioral Problems (SBP) at 8 weeks in children aged 6 - 18 years with Intellectual Disa…
Phase 2 • Sponsor: Murdoch Childrens Research Institute • Aim: Symptom relief
Last updated Jun 26, 2026 13:23 UTC
-
New balloon treatment aims to clear blocked stents without extra surgery
Disease control OngoingAGENT IDE is a Prospective, Randomized (2:1), Multicenter Trial. The purpose of this study is to assess the safety and effectiveness of the Agent Paclitaxel Coated PTCA Balloon Catheter compared to balloon angioplasty (POBA) in patients with in-stent restenosis (ISR) of a previou…
Phase 3 • Sponsor: Boston Scientific Corporation • Aim: Disease control
Last updated Aug 28, 2026 00:00 UTC
-
Could a blood pressure pill protect your liver from cancer?
Disease control OngoingThis phase II trial investigates how well lisinopril may work in preventing the progression of non-alcoholic fatty liver disease (NAFLD). NAFLD is a condition where there is an accumulation of fatty cells in the liver. NAFLD increases a person's risk of developing liver cancer. L…
Phase 2 • Sponsor: Northwestern University • Aim: Disease control
Last updated Aug 16, 2026 00:00 UTC
-
New cocktail of drugs takes on Hard-to-Treat colon cancer
Disease control CompletedThis randomized phase 1b/2 open-label study will evaluate the antitumour activity and safety of etrumadenant (AB928) treatment combinations in participants with metastatic colorectal cancer.
Phase 1/2 • Sponsor: Arcus Biosciences, Inc. • Aim: Disease control
Last updated Jun 27, 2026 07:55 UTC
-
Could a fitbit and phone coaching help women with depression stay sober?
Disease control OngoingThe primary aim of this project is to test the efficacy of a technology-supported lifestyle physical activity (LPA) intervention for preventing relapse among women with depression engaged in alcohol treatment. Participants are randomized to either 1) LPA+Fitbit intervention or 2)…
Sponsor: Butler Hospital • Aim: Disease control
Last updated Jul 01, 2026 00:00 UTC
-
Could tailored brain stimulation quiet Parkinson's tremors more effectively?
Disease control Recruiting nowThis is an open-label, non-randomized, proof-of-concept comparison of clinical vs. research stimulation patterns in patients with Parkinson's disease (PD) being treated with Deep Brain Stimulation (DBS) through the Medtronic Percept PC DBS device. The investigators hypothesize th…
Sponsor: University of Nebraska • Aim: Disease control
Last updated Jul 24, 2026 00:00 UTC
-
New hope for transplant patients: drug may tame chronic GVHD without steroids
Disease control CompletedBackground: \- Chronic Graft Versus Host Disease (cGVHD) can occur after a person has had a stem cell or bone marrow transplant. In cGVHD, the donor cells attack the recipient's body. Researchers want to see if a drug called ibrutinib can block one of the proteins that lead to t…
Phase 2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Jun 27, 2026 08:13 UTC
-
Could a Light-Based blood treatment help Early-Stage skin cancer patients?
Disease control Recruiting nowThe purpose of this study is to determine whether photopheresis therapy can be used to improve the clinical course of early stage cutaneous T-cell lymphoma (CTCL). Currently, photopheresis is performed as a palliative treatment for late stage CTCL. However, recent studies have de…
Phase 2 • Sponsor: Columbia University • Aim: Disease control
Last updated Jun 27, 2026 12:24 UTC
-
New antibiotic cocktail aims to slash infection risk in severe bone breaks
Disease control Recruiting nowThe PRCT evaluates infection outcomes as well as fracture and antibiotic-related complications to include the emergence of resistant bacteria associated with two different antibiotic strategies in the treatment of Gustilo type IIIB tibia and hindfoot fractures (calcaneus and talu…
Phase 3 • Sponsor: Major Extremity Trauma Research Consortium • Aim: Disease control
Last updated Jul 24, 2026 00:00 UTC
-
New hope for advanced cancers? JAB-8263 enters human testing
Disease control Recruiting nowThis is a Phase 1/2a, first-in-human, open-label study of JAB-8263, this study has two parts: solid tumor dose escalation and expansion study and hematology tumor dose escalation and expansion study. These two parts will determine the maximum tolerated dose (MTD), recommended Ph…
Phase 1/2 • Sponsor: Jacobio Pharmaceuticals Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 08:10 UTC
-
New drug combo targets Hard-to-Treat cancers
Disease control Ongoing* To evaluate the safety and tolerability of ERAS-007 monotherapy administered once weekly (QW) and twice daily-once weekly (BID-QW). * To determine the Maximum Tolerated Dose (MTD) and/or Recommended Dose (RD) of ERAS-007 monotherapy administered BID-QW. * To characterize the ph…
Phase 1/2 • Sponsor: Erasca, Inc. • Aim: Disease control
Last updated Jun 27, 2026 14:01 UTC
-
Can a simple blood test flag hidden heart risks after stenting?
Knowledge-focused Recruiting nowCoronary heart disease (CAD) is caused by myocardial ischemia, hypoxia or necrosis due to coronary artery stenosis, spasm or obstruction. Although standard drug therapy can greatly improve the prognosis of patients with CAD after percutaneous coronary interventions (PCI), these p…
Sponsor: Union Hospital, Tongji Medical College, Huazhong University of Science and Technology • Aim: Knowledge-focused
Last updated Sep 04, 2026 00:00 UTC
-
Could a thyroid hormone boost fertility in PCOS? new trial tests combination therapy
Disease control Recruiting nowThe goal of this randomized controlled trial is to compare letrozole alone versus letrozole plus levothyroxine for ovulation induction in infertile women with both PCOS and subclinical hypothyroidism. The main questions it aims to answer are: Is letrozole plus levothyroxine supe…
Sponsor: Muhamed Ahmed Abdelmoaty Muhamed Alhagrasy • Aim: Disease control
Last updated Jun 26, 2026 12:45 UTC
-
Heart drug aficamten tested for Long-Term safety in 900 patients
Disease control By invitation onlyThe purpose of this study is to collect long-term safety and tolerability data for aficamten.
Phase 2/3 • Sponsor: Cytokinetics • Aim: Disease control
Last updated Jun 27, 2026 08:12 UTC
-
Can early surgery stop brain tumors from returning?
Disease control PausedThis clinical trial evaluates the side effects and possible benefits of operating on brain tumors prior to the tumor coming back (recurrence). Understanding when surgery is most useful to patients with brain tumors is important. Some patients may undergo chemotherapy or radiation…
Sponsor: Mayo Clinic • Aim: Disease control
Last updated Aug 07, 2026 00:00 UTC
-
Brain scans could reveal which MS drugs fight mental exhaustion
Knowledge-focused CompletedThe purpose of this research study is to investigate the effectiveness of MS Disease modifying medications on cognitive fatigue in persons with relapsing remitting multiple sclerosis (RRMS). Cognitive fatigue is the kind of fatigue that occurs after intense mental concentration a…
Sponsor: Kessler Foundation • Aim: Knowledge-focused
Last updated Aug 13, 2026 00:00 UTC
-
New hope for moms with hepatitis b: drug may stop baby from getting the virus
Disease control Recruiting nowThe purpose of this study is to evaluate the pharmacokinetics, efficacy and safety of TAF in HBV-infected pregnant women.
Phase 4 • Sponsor: First People's Hospital of Hangzhou • Aim: Disease control
Last updated Jun 26, 2026 15:20 UTC
-
Can tracking a rare eye cancer pave the way for new treatments?
Knowledge-focused OngoingThe overall objective of this proposal is to develop and utilize a multicenter UM registry that will, in a longitudinal fashion, capture prospective data in order to characterize the natural history of UM and provide data that will be used to support the development of novel ther…
Sponsor: Columbia University • Aim: Knowledge-focused
Last updated Aug 13, 2026 00:00 UTC
-
New drug takes aim at Hard-to-Treat blood cancers
Disease control Recruiting nowThis is a first-in-human Phase 1a/1b multicenter, open-label oncology study designed to evaluate the safety and anti-cancer activity of NX-2127 in patients with advanced B-cell malignancies.
Phase 1 • Sponsor: Nurix Therapeutics, Inc. • Aim: Disease control
Last updated Jun 27, 2026 11:03 UTC
-
New drug aims to slow Parkinson's progression in early stages
Disease control OngoingThis is a multicenter, randomized, double-blind, placebo-controlled study that will evaluate the efficacy and safety of intravenous (IV) prasinezumab versus placebo in participants with Early Parkinson's Disease (PD) who are on stable symptomatic PD medication.
Phase 2 • Sponsor: Hoffmann-La Roche • Aim: Disease control
Last updated Sep 06, 2026 00:00 UTC